STAA Q2 2019 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q2 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$40M+17.0% YoY

Gross Profit

$30M75.4% margin

Operating Income

$5M11.6% margin

Net Income

$4M9.9% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+21.7%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$186M

Total Liabilities

$42M

Stockholders' Equity

$144M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$34M	+17.0%
Gross Profit	$30M	$25M	+18.5%
Operating Income	$5M	$3M	+52.4%
Net Income	$4M	$2M	+113.9%

Revenue Segments

Implantable Collamer Lenses

$34M87%

Intraocular Lenses

$4M10%

Other Surgical Products

$1M3%

Geographic Segments

CHINA

$19M49%

Other Countries

$14M35%

JAPAN

$6M16%